180 related articles for article (PubMed ID: 12572998)
1. Antimalarial effect of iron chelators.
Gordeuk VR; Loyevsky M
Adv Exp Med Biol; 2002; 509():251-72. PubMed ID: 12572998
[No Abstract] [Full Text] [Related]
2. Effects of hydroxypyridinone iron chelators in combination with antimalarial drugs on the in vitro growth of Plasmodium falciparum.
Pattanapanyasat K; Kotipun K; Yongvanitchit K; Hider RC; Kyle DE; Heppner DG; Walsh DS
Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):64-9. PubMed ID: 11485097
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric assessment of hydroxypyridinone iron chelators on in vitro growth of drug-resistant malaria.
Pattanapanyasat K; Thaithong S; Kyle DE; Udomsangpetch R; Yongvanitchit K; Hider RC; Webster HK
Cytometry; 1997 Jan; 27(1):84-91. PubMed ID: 9000589
[TBL] [Abstract][Full Text] [Related]
4. Control of malaria by drug-mediated iron deprivation.
Hershko C; Cabantchik ZI
Isr J Med Sci; 1994 Nov; 30(11):840-5. PubMed ID: 7982777
[No Abstract] [Full Text] [Related]
5. The combined effect of iron chelators and classical antimalarials on the in-vitro growth of Plasmodium falciparum.
van Zyl RL; Havlik I; Monteagudo FS
J Antimicrob Chemother; 1992 Sep; 30(3):273-8. PubMed ID: 1452491
[TBL] [Abstract][Full Text] [Related]
6. In vitro antimalarial activity of ICL670: a further proof of the correlation between inhibition of β-hematin formation and of peroxidative degradation of hemin.
Sonnet P; Mullié C
Exp Parasitol; 2011 May; 128(1):26-31. PubMed ID: 21295029
[TBL] [Abstract][Full Text] [Related]
7. The effect of N-alkyl modification on the antimalarial activity of 3-hydroxypyridin-4-one oral iron chelators.
Hershko C; Theanacho EN; Spira DT; Peter HH; Dobbin P; Hider RC
Blood; 1991 Feb; 77(3):637-43. PubMed ID: 1991172
[TBL] [Abstract][Full Text] [Related]
8. The antimalarial effect of iron chelators: studies in animal models and in humans with mild falciparum malaria.
Hershko C; Gordeuk VR; Thuma PE; Theanacho EN; Spira DT; Hider RC; Peto TE; Brittenham GM
J Inorg Biochem; 1992 Aug 15-Sep; 47(3-4):267-77. PubMed ID: 1431886
[TBL] [Abstract][Full Text] [Related]
9. Iron chelation therapy for malaria.
Gordeuk VR; Thuma PE; Brittenham GM
Adv Exp Med Biol; 1994; 356():371-83. PubMed ID: 7887243
[No Abstract] [Full Text] [Related]
10. Deferiprone (L1) as an adjuvant therapy for Plasmodium falciparum malaria.
Mohanty D; Ghosh K; Pathare AV; Karnad D
Indian J Med Res; 2002 Jan; 115():17-21. PubMed ID: 12424933
[TBL] [Abstract][Full Text] [Related]
11. Deferoxamine effects on Plasmodium falciparum gene expression.
Moormann AM; Hossler PA; Meshnick SR
Mol Biochem Parasitol; 1999 Jan; 98(2):279-83. PubMed ID: 10080396
[No Abstract] [Full Text] [Related]
12. Antimalarial iron chelator, FBS0701, shows asexual and gametocyte Plasmodium falciparum activity and single oral dose cure in a murine malaria model.
Ferrer P; Tripathi AK; Clark MA; Hand CC; Rienhoff HY; Sullivan DJ
PLoS One; 2012; 7(5):e37171. PubMed ID: 22629364
[TBL] [Abstract][Full Text] [Related]
13. Exploration of 4(1H)-pyridones as a novel family of potent antimalarial inhibitors of the plasmodial cytochrome bc1.
Bueno JM; Herreros E; Angulo-Barturen I; Ferrer S; Fiandor JM; Gamo FJ; Gargallo-Viola D; Derimanov G
Future Med Chem; 2012 Dec; 4(18):2311-23. PubMed ID: 23234553
[TBL] [Abstract][Full Text] [Related]
14. Iron chelators: mode of action as antimalarials.
Cabantchik ZI; Glickstein H; Golenser J; Loyevsky M; Tsafack A
Acta Haematol; 1996; 95(1):70-7. PubMed ID: 8604590
[TBL] [Abstract][Full Text] [Related]
15. Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu).
Meshnick SR; Yang YZ; Lima V; Kuypers F; Kamchonwongpaisan S; Yuthavong Y
Antimicrob Agents Chemother; 1993 May; 37(5):1108-14. PubMed ID: 8517699
[TBL] [Abstract][Full Text] [Related]
16. Antimalarial action of hydroxamate-based iron chelators and potentiation of desferrioxamine action by reversed siderophores.
Golenser J; Tsafack A; Amichai Y; Libman J; Shanzer A; Cabantchik ZI
Antimicrob Agents Chemother; 1995 Jan; 39(1):61-5. PubMed ID: 7695330
[TBL] [Abstract][Full Text] [Related]
17. Iron chelating agents for treating malaria.
Smith HJ; Meremikwu M
Cochrane Database Syst Rev; 2003; (2):CD001474. PubMed ID: 12804409
[TBL] [Abstract][Full Text] [Related]
18. Malaria: to kill a parasite.
Ridley RG
Nature; 2003 Aug; 424(6951):887-9. PubMed ID: 12931167
[No Abstract] [Full Text] [Related]
19. Antimalarial properties of orally active iron chelators.
Heppner DG; Hallaway PE; Kontoghiorghes GJ; Eaton JW
Blood; 1988 Jul; 72(1):358-61. PubMed ID: 3291984
[TBL] [Abstract][Full Text] [Related]
20. Malaria pigment and extracellular iron. Possible target for iron chelating agents.
van Zyl RL; Havlik I; Hempelmann E; MacPhail AP; McNamara L
Biochem Pharmacol; 1993 Apr; 45(7):1431-6. PubMed ID: 8471067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
